All In Biotech

Drug Trial Radar · NCT07581470

Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty

Trial Evaluating Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 198 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

198

Planned (sponsor's estimate)

Start

May 8, 2026

Primary completion

Jun 30, 2027

Study completion Jul 31, 2027

Sponsor

Lead sponsor
Poznan University of Medical SciencesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

his study will test whether giving dexamethasone through a vein can improve pain control after total hip replacement surgery. Dexamethasone is commonly used to reduce nausea and may also help with pain, but it is not clear which dose works best. Patients will be randomly assigned to receive either no dexamethasone, 4 mg, or 8 mg, in addition to standard anesthesia and a nerve block (PENG block). The main goal is to see how long patients go without needing additional pain medication after surgery. The study will also look at pain levels, use of opioid painkillers, nausea and vomiting, blood sugar levels, and possible side effects.

Conditions

  • Osteoarthritis, Hip
  • Hip Osteoarthritis

Interventions

  • Dexamethasone 4mgDrug

    Intravenous dexamethasone administered as a single dose after induction of anesthesia, at doses of 4 mg

  • PlaceboDrug

    Intravenous administration of 0.9% sodium chloride in a volume identical to active treatment, given after induction of anesthesia.

  • Dexamethasone 8mgDrug

    Intravenous dexamethasone administered as a single dose after induction of anesthesia, at doses of 8 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to First Rescue AnalgesiaTime frame: 48 hours after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Poznan University of Medical Sciences

    Poznan, Poland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.